<HTML>
<HEAD>
   <TITLE>Appendices</TITLE>
<META NAME="AUTHOR" CONTENT="William White">
</HEAD>
<BODY BGCOLOR="#FFFFFF">
<P><BR>
</P>

<P><BR>
</P>

<P><BR>
</P>

<CENTER><A NAME="toc.15"></A></CENTER>

<H1><CENTER>15 &nbsp; Appendices</CENTER></H1>

<P><BR>
</P>

<P><BR>
</P>

<P><BR>
</P>

<P><BR>

<HR SIZE=4>

</P>

<P><BR>
</P>

<P><BR>
</P>

<CENTER><A NAME="toc.15.1"></A></CENTER>

<H2><CENTER>15.1 &nbsp; Appendix 1: P450 Inhibiting
Drugs</CENTER></H2>

<P><BR>
This is a partial list of recreational and medical drugs which
inhibit the P450 enzymes 2D6, 3A4, and 3A5. Not all of them will
inhibit all of the P450 enzymes, but it's safe to say that a
substantial number of these will interact with DXM.</P>

<P>Generally speaking, inhibitors of P450-2D6 include antidepressants
(both SSRIs and tricyclics, and possibly MAO inhibitors),
antiparasitics (especially antimalarials), antihistamines (both
prescription and over-the-counter), neuroleptics, beta blockers
(drugs for high blood pressure), and antineoplastics (anti-cancer
drugs). Methadone is a P450-2D6 inhibitor, and it is likely that many
alkaloids, especially of plant origin, may be mild to moderate
P450-2D6 inhibitors. <TABLE BORDER=1><CAPTION>P450 Inhibitors</CAPTION>
   <TR>
      <TH>
         <P>Drug</P>
      </TH>
      <TH>
         <P>Uses</P>
      </TH>
      <TH>
         <P>P450-2D Enzymes</P>
      </TH>
      <TH>
         <P>Potency</P>
      </TH>
      <TH>
         <P>Ref</P>
      </TH>
   </TR>
   <TR>
      <TD>
         <P>ajmalicine</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>strongest</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r164">164</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>carbon monoxide</P>
      </TD>
      <TD>
         <P>poison</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r160">160</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>chloroquine</P>
      </TD>
      <TD>
         <P>antiparasitic</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r172">172</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>chlorpheniramine</P>
      </TD>
      <TD>
         <P>antihistamine</P>
      </TD>
      <TD>
         <P>2D</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r151">151</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>citalopram</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r166">166</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>clozapine</P>
      </TD>
      <TD>
         <P>antipsychotic</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r171">171</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>desipramine</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r152">152</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>diphenhydramine</P>
      </TD>
      <TD>
         <P>antihistamine</P>
      </TD>
      <TD>
         <P>2D</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r151">151</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>doxorubicin</P>
      </TD>
      <TD>
         <P>anticancer</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r165">165</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>fluoxetine</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r152">152</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>fluvoxamine</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r152">152</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>imipramine</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r152">152</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>lomustine</P>
      </TD>
      <TD>
         <P>anticancer</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r165">165</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>mepyramine</P>
      </TD>
      <TD>
         <P>antihistamine</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r151">151</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>methadone</P>
      </TD>
      <TD>
         <P>addiction treatment</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r162">162</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>moclobemide</P>
      </TD>
      <TD>
         <P>MAO-A Inh. (reversible)</P>
      </TD>
      <TD>
         <P>2D6, also 2C19, 1A2</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r147">147</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>nortryptiline</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r155">155</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>oxamniquine</P>
      </TD>
      <TD>
         <P>antiparasitic</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r172">172</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>paroxetine</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r152">152</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>PCP</P>
      </TD>
      <TD>
         <P>recreational</P>
      </TD>
      <TD>
         <P>2D</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r150">150</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>primaquine</P>
      </TD>
      <TD>
         <P>antiparasitic</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r172">172</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>propranolol</P>
      </TD>
      <TD>
         <P>beta-blocker</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r156">156</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>quinidine</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r148">148</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>quinine</P>
      </TD>
      <TD>
         <P>antiparasitic</P>
      </TD>
      <TD>
         <P>2D</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r151">151</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>sertraline</P>
      </TD>
      <TD>
         <P>antidepressant</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r167">167</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>triprolidine</P>
      </TD>
      <TD>
         <P>antihistamine</P>
      </TD>
      <TD>
         <P>2D</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r151">151</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>vinblastine</P>
      </TD>
      <TD>
         <P>anticancer</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r165">165</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>vinorelbine</P>
      </TD>
      <TD>
         <P>anticancer</P>
      </TD>
      <TD>
         <P>2D6</P>
      </TD>
      <TD>
         <P>med-low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r165">165</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
   </TR>
   <TR>
      <TH>
         <P>Drug</P>
      </TH>
      <TH>
         <P>Uses</P>
      </TH>
      <TH>
         <P>P450-3A Enzymes</P>
      </TH>
      <TH>
         <P>Potency</P>
      </TH>
      <TH>
         <P>Ref</P>
      </TH>
   </TR>
   <TR>
      <TD>
         <P>7,8-benzoflavone</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>3A4 (activator)</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r153">153</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>cannabidiol</P>
      </TD>
      <TD>
         <P>component of marijuana</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>med</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r161">161</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>cocaine</P>
      </TD>
      <TD>
         <P>recreational</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r157">157</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>clotrimazole</P>
      </TD>
      <TD>
         <P>agricultural fungicide</P>
      </TD>
      <TD>
         <P>3A (activator)</P>
      </TD>
      <TD>
         <P>very high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r154">154</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>cyclophosphamide</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>low?</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r158">158</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>ifosfamide</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>low?</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r158">158</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>ketoconazole</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r145">145</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>pilocarpine</P>
      </TD>
      <TD>
         <P>cholinomimetic</P>
      </TD>
      <TD>
         <P>3A</P>
      </TD>
      <TD>
         <P>low</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r149">149</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
      <TD>
         <P></P>
      </TD>
   </TR>
   <TR>
      <TH>
         <P>Drug</P>
      </TH>
      <TH>
         <P>Uses</P>
      </TH>
      <TH>
         <P>P450-3A Enzymes</P>
      </TH>
      <TH>
         <P>Potency</P>
      </TH>
      <TH>
         <P>Ref</P>
      </TH>
   </TR>
   <TR>
      <TD>
         <P>1-aminobenzotriazole</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>Nonspecific</P>
      </TD>
      <TD>
         <P>med-high</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r159">159</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>chlorophyllin</P>
      </TD>
      <TD>
         <P>geriatric</P>
      </TD>
      <TD>
         <P>Nonspecific</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r146">146</A>)</P>
      </TD>
   </TR>
   <TR>
      <TD>
         <P>general anaesthetics</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>Nonspecific</P>
      </TD>
      <TD>
         <P>&nbsp;</P>
      </TD>
      <TD>
         <P>(<A HREF="refs.html#r163">163</A>)</P>
      </TD>
   </TR>
</TABLE>
</P>

<P>One reference ((<A HREF="refs.html#r164">164</A>)) gives the
general characteristics of P450-2D6 inhibitors as<BR>
<QUOT>a positive charge on a nitrogen atom, and a flat hydrophobic
region, the plane of which is almost perpendicular to the N-H axis
and maximally extends up to a distance of 7.5 A from the nitrogen
atom. Compounds with high inhibitory potency had additional
functional groups with negative molecular electrostatic potential and
hydrogen bond acceptor properties on the opposite side at respective
distances of 4.8-5.5A and 6.6-7.5A from the nitrogen atom.</QUOT><BR>
A computer model of the P450-2D6 cytochrome has been constructed
((<A HREF="refs.html#r170">170</A>)).</P>

<P><BR>
</P>

<P><BR>
</P>

<P><BR>

<HR SIZE=4>

</P>

<P><BR>
</P>

<P><BR>
</P>

<CENTER><A NAME="toc.15.2"></A></CENTER>

<H2><CENTER>15.2 &nbsp; Appendix 2: Neuropharmacology of Recreational
Drugs</CENTER></H2>

<P><BR>
</P>

<DL>
   <DT>2CB</DT>
   
   <DD>Like many phenethylamines, has mixed properties of a dopamine
   releasing agent, serotonin (5HT) releasing agent, and probably
   binding specifically to 5HT receptors (likely including 5HT2A and
   5HT2C). Compare amphetamine, MDA.</DD>
   
   <DT>alcohol</DT>
   
   <DD>Mechanism unknown; may affect membrane permeability or alter
   ion channel function. Functionally potentiates GABAergic activity
   and blocks NMDA receptors, and also has actions on other ion
   channel receptors.</DD>
   
   <DT>amyl nitrate</DT>
   
   <DD>Vasodilator; recreational effects probably derive from this
   effect rather than being specific to a set of receptors.</DD>
   
   <DT>amphetamine</DT>
   
   <DD>Causes a non-vesicular release of dopamine and noradrenaline
   by neurons which normally secrete them. May have some direct
   effect on dopamine and noradrenaline receptors, but this is
   insignificant compared to its neurotransmitter releasing
   effect.</DD>
   
   <DT>barbiturates</DT>
   
   <DD>Targets and binds to a specific site (called the picrotoxin
   site) on GABA receptors, which activates them. This is a different
   site from alcohol and benzodiazepines, so that if you combine any
   of these three, they will not compete for the same binding sites.
   Consequently, there is a synergistic effect, which can be quite
   dangerous.</DD>
   
   <DT>benzodiazepines</DT>
   
   <DD>Similar to barbiturates, except for two factors. First, the
   binding site is the benzodiazepine site on the GABA receptor.
   Second, when a benzodiazepine binds to this site, the GABA
   receptor is not immediately activated; instead, the natural action
   of GABA is enhanced. This is the main reason benzodiazepines are
   safer than barbiturates, and have different effects.</DD>
   
   <DT>"blues"</DT>
   
   <DD>An antihistamine (targeting and activating the H<SUB>1</SUB>
   receptor) which probably has sigma<SUB>1</SUB> antagonist
   properties; when used in combination with pentazocine, it probably
   blocks the sigma activity of the latter. Rarely found. The only
   reason I'm mentioning it is because I heard about it in a comedy
   skit called "Rock and Roll Doctor" and always wondered what
   "blues" were (until I found out). Well, if you wondered too, now
   you know.</DD>
   
   <DT>caffeine</DT>
   
   <DD>Targets and blocks an adenosine receptor, probably
   A<SUB>2</SUB> but possibly A<SUB>1</SUB>. This is an inhibitory
   presynaptic receptor, i.e., when activated it decreases the amount
   of neurotransmitter released by a neuron. Thus, caffeine blocks
   some of this inhibition, increasing neural activity.</DD>
   
   <DT>cannabis</DT>
   
   <DD>Targets a specific receptor (or family of receptors)
   designated anandamide. It is not yet known whether cannabis
   (actually, THC) is an agonist or antagonist at this receptor,
   although most think it is an agonist.</DD>
   
   <DT>codeine</DT>
   
   <DD>See morphine.</DD>
   
   <DT>coffee</DT>
   
   <DD>See caffeine.</DD>
   
   <DT>cocaine</DT>
   
   <DD>A dopamine reuptake inhibitor; cocaine blocks the transporter
   which takes used dopamine out of the way. Thus, dopamine secreted
   by a neuron keeps activating receptors over and over. Cocaine is
   also a sigma<SUB>1</SUB> agonist, and has blocking abilities on
   certain ion channels (by which it exerts its local anesthetic
   effects).</DD>
   
   <DT>Demerol</DT>
   
   <DD>See morphine.</DD>
   
   <DT>glue</DT>
   
   <DD>See solvents.</DD>
   
   <DT>heroin</DT>
   
   <DD>See morphine.</DD>
   
   <DT>ketamine</DT>
   
   <DD>Blocks NMDA receptors at the same site as DXM and PCP.</DD>
   
   <DT>LSD</DT>
   
   <DD>Targets 5HT<SUB>2A</SUB> and 5HT<SUB>2C</SUB>, where it acts
   either as an antagonist or a partial agonist. Also has some
   dopaminergic activity; however, the majority of its effects are
   mediated through the 5HT receptors.</DD>
   
   <DT>marijuana</DT>
   
   <DD>See cannabis.</DD>
   
   <DT>MDA</DT>
   
   <DD>See MDMA. Release binding spectrum is probably different, and
   MDA may have additional effects on receptors.</DD>
   
   <DT>MDMA</DT>
   
   <DD>Similar to amphetamine, except that MDMA causes a nonvesicular
   release of dopamine and serotonin (5HT). Probably has other
   effects as well, some of which may be significant.</DD>
   
   <DT>methamphetamine</DT>
   
   <DD>Similar to amphetamine, possibly with more dopamine
   release.</DD>
   
   <DT>morphine</DT>
   
   <DD>Targets opioid receptors mu, kappa, and delta, where it acts
   as an agonist. Slight differences in binding spectrum to opiate
   receptors exist among the various natural and synthetic
   opiates.</DD>
   
   <DT>nicotine</DT>
   
   <DD>Stimulates and then blocks nicotinic acetylcholine
   receptors.</DD>
   
   <DT>nitrous oxide</DT>
   
   <DD>Seems to affect phospholipid membranes, although some effects
   may be mediated by NMDA and GABA channels, and other ion channels.
   General anesthetics are similar to nitrous oxide, although more
   toxic.</DD>
   
   <DT>opium</DT>
   
   <DD>See morphine.</DD>
   
   <DT>PCP (phencyclidine)</DT>
   
   <DD>PCP and related cycloarylpiperidines block NMDA receptors, as
   well as having a variety of other effects, including sigma
   agonism, dopamine reuptake inhibition, and specific effects on an
   unknown cerebellar receptor.</DD>
   
   <DT>Poppers</DT>
   
   <DD>See amyl nitrate</DD>
   
   <DT>Psilocybin (mushrooms)</DT>
   
   <DD>Similar to LSD; acts via 5HT2A and 2C receptors and possibly
   additional ones.</DD>
   
   <DT>Quaaludes (methaqualone)</DT>
   
   <DD>See barbiturates.</DD>
   
   <DT>Ritalin</DT>
   
   <DD>Similar to cocaine, but less potent.</DD>
   
   <DT>Rohypnol</DT>
   
   <DD>See benzodiazepines.</DD>
   
   <DT>seconal</DT>
   
   <DD>See barbiturates.</DD>
   
   <DT>solvents</DT>
   
   <DD>Same general theory as alcohol and nitrous oxide, but
   considerably more toxic to neurons (and the liver).</DD>
   
   <DT>Valium&#91;tm&#93;</DT>
   
   <DD>See benzodiazepines.</DD>
   
   <DT>yohimbine</DT>
   
   <DD>Targets and blocks alpha2 adrenergic receptors. These are
   autoreceptors, which normally limit the activity of adrenergic
   neurons. By blocking alpha<SUB>2</SUB> receptors, yohimbine
   increases the activity of these neurons.</DD>
</DL>

<P><BR>
</P>

<P><BR>
</P>

<P><BR>

<HR SIZE=4>

</P>

<P><BR>
</P>

<P><BR>
</P>

<CENTER><A NAME="toc.15.3"></A></CENTER>

<H2><CENTER>15.3 &nbsp; Appendix 3: Other Sigma and NMDA
Ligands</CENTER></H2>

<P><BR>
Here are a few sigma ligands you may wish to research (if you are
interested in that sort of thing):</P>

<P>Sigma<SUB>1</SUB> ligands in rough order of potency:</P>

<UL>
   <LI>(+)-pentazocine</LI>
   
   <LI>haloperidol</LI>
   
   <LI>DTG</LI>
   
   <LI>(+)-3-PPP</LI>
   
   <LI>DXM</LI>
   
   <LI>(+)-SKF 10,047</LI>
   
   <LI>(+)-cyclazocine</LI>
   
   <LI>(-)-pentazocine</LI>
   
   <LI>PCP</LI>
   
   <LI>(-)-SKF 10,047</LI>
</UL>

<P><BR>
</P>

<P>Sigma<SUB>2</SUB> ligands in rough order of potency:</P>

<UL>
   <LI>DTG</LI>
   
   <LI>haloperidol</LI>
   
   <LI>(+)-3-PPP</LI>
   
   <LI>(-)-pentazocine</LI>
   
   <LI>PCP</LI>
   
   <LI>(+)-pentazocine</LI>
   
   <LI>(-)-SKF 10,047</LI>
</UL>

<P><BR>
P&gt; A known sigma antagonist is
N-&#91;-2-(3,4-dichlorophenyl)ethyl&#93;- N-methyl-2-&#91;1-
pyrimidinyl-1-piperazine&#93; butanol; a sigma<SUB>1</SUB> selective
antagonist is (1-(cyclopropylmethyl)- 4-2'4"-fluorophenyl)-
(2'-oxoethyl)piperidine HBr.</P>
</BODY>
</HTML>
